Estimating the period prevalence of SARS-CoV-2 infection during the Omicron (BA.1) surge in New York City (NYC), January 1-March 16, 2022.

Saba A QasmiehMcKaylee M RobertsonChloe A TeasdaleSarah G KulkarniDenis Nash

Published in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2022)

In a population-based survey of NYC adults, we assessed positive SARS-CoV-2 tests (including via exclusive at-home testing) and possible cases among untested respondents. An estimated 27.4% (95%CI: 22.8%-32.0%) or 1.8 million adults (95%CI: 1.6-2.1 million) had SARS-CoV-2 infection between January 1 and March 16, 2022.

Keyphrases

sars cov
respiratory syndrome coronavirus
risk factors
cross sectional
coronavirus disease